A penile traction device is a mechanical frame worn on the penis that applies a low, sustained stretch over hours per day to gradually lengthen tissue or reduce curvature. The principle behind it is the same one orthopedic surgeons have used for decades to lengthen bones and soft tissues elsewhere in the body: cells respond to prolonged mechanical force by remodeling and growing. In urology, these devices are used primarily for Peyronie’s disease (a condition where scar tissue causes the penis to bend) and, to a lesser extent, for penile lengthening or recovery after surgery. The evidence base has grown steadily, with randomized trials and a recent meta-analysis showing measurable reductions in curvature and gains in length, though the results depend heavily on how many hours per day you actually wear the thing.
How the Device Works Physically
Most penile traction devices share the same basic design. A ring or cradle sits at the base of the penis, a second attachment grips the head (usually with a silicone strap, noose, or vacuum cup), and adjustable rods or springs connect the two ends. You extend the rods incrementally so that the device holds the penis in a gentle stretch. The tension is typically between 500 and 1,500 grams of force, and you gradually increase it over weeks as the tissue adapts.
Some newer designs allow you to direct the stretch in a specific direction. If your penis curves to the left, for instance, a device with an adjustable fulcrum can apply more traction to the shorter side. This matters for Peyronie’s disease, where the goal is not just to add length overall but to straighten the curve by preferentially stretching the scarred area.
The typical protocol asks you to wear the device for several hours a day, usually somewhere between two and eight hours, for a period of three to six months. That daily time commitment is the single biggest obstacle most people face, and studies consistently note that compliance is a challenge.
The Biology Behind Traction
The underlying biological process is called mechanotransduction, which is just a technical way of saying that cells can sense physical force and change their behavior in response. When you stretch tissue slowly and persistently, cells within that tissue receive signals to divide, produce new collagen, and remodel the surrounding matrix. Over weeks and months, this adds actual tissue rather than merely stretching what is already there.
Laboratory work has shown what happens at the cellular level in Peyronie’s disease tissue under strain. When fibrotic cells from Peyronie’s plaques were placed in a mechanical stretching system, the strain increased an enzyme involved in breaking down scar tissue (a metalloproteinase) while reducing markers associated with the scarring process itself.
1The Journal of Sexual Medicine. Peyronie’s Disease and Mechanotransduction: An In Vitro Analysis of the Cellular Changes to Peyronie’s Disease in a Cell‐Culture Strain SystemIn plain terms, the stretch appears to push scar cells toward breaking down rather than building up more scar. That is the theoretical reason traction can reduce curvature and not just add length: it is actively remodeling the plaque, not just pulling around it.
Evidence for Peyronie’s Disease
Peyronie’s disease is the clinical setting where traction devices have the strongest evidence. The condition affects roughly one in ten men at some point in their lives (though many cases go unreported), and it can cause pain, a visible bend during erection, penile shortening, and difficulty with intercourse. Traction therapy has been studied as a standalone treatment and as an add-on to other treatments.
A meta-analysis pooling data from multiple studies found a statistically significant effect on curvature, with a mean improvement of about 16 degrees.
2PubMed Central. The effect of penile traction device in men with Peyronie’s disease on penile curvature, penile length, and erectile dysfunction: a systematic review and meta-analysisIndividual trials paint a more detailed picture. In a randomized controlled trial, men using a traction device for three months saw their curvature improve by about 12 degrees on average compared to a control group that saw essentially no change. About three-quarters of men on traction experienced some degree of curvature improvement, and nearly all achieved increased length, averaging about 1.5 cm.
3PubMed. Outcomes of a Novel Penile Traction Device in Men with Peyronie’s Disease: A Randomized, Single-Blind, Controlled TrialThe most dramatic results come from studies with longer wear times. A controlled multicentre study using a different device found an overall curvature reduction of about 31 degrees (roughly 41% improvement) at 12 weeks. The key finding was a clear dose-response relationship: men who wore the device for fewer than four hours daily saw reductions of about 20 degrees, while those who managed more than six hours daily saw reductions averaging 38 degrees.
4PubMed. Penile traction therapy with the new device ‘Penimaster PRO’ is effective and safe in the stable phase of Peyronie’s disease: a controlled multicentre studyThat dose-response pattern keeps appearing across studies and is probably the most consistent finding in this literature. The more hours you put in, the better the results. It also explains the wide range of outcomes people report: someone wearing the device for an hour a day should not expect the same results as someone wearing it for six.
Combining Traction with Other Treatments
Traction therapy does not have to be used alone. One of the more promising approaches pairs it with collagenase injections, an FDA-approved injectable treatment that breaks down Peyronie’s plaque chemically. A study comparing three groups found that combining collagenase injections with traction therapy produced substantially better results than either treatment alone. The combination group achieved about a 34-degree improvement in curvature (49% improvement) and gained nearly 2 cm in length, while the injection-only and traction-only groups saw improvements in the 19 to 20-degree range with slight length losses.
5The Journal of Sexual Medicine. Efficacy of Combined Collagenase Clostridium histolyticum and RestoreX Penile Traction Therapy in Men with Peyronie’s DiseaseThe combination group also used the traction device for fewer hours per day (about one hour versus two), which suggests the injections may prime the tissue to respond more readily to mechanical force. For men who struggle with wearing a device for many hours, this kind of synergy could make a real difference in what is achievable.
Vacuum erection devices are sometimes used for similar goals. In one study of men with Peyronie’s disease who used a vacuum device for traction, the mean curvature improvement was about 23 degrees, while untreated patients improved by only about 4 degrees.
6PubMed Central. Outcome analysis of patients with Peyronie’s disease who elect for vacuum erection device therapyThe mechanisms are somewhat different since vacuum devices use circumferential pressure rather than longitudinal stretch, but both appear to promote tissue remodeling.
Penile Lengthening Without Disease
Outside the Peyronie’s disease context, traction devices have been studied for penile lengthening in men who perceive their penis as short. The evidence here is thinner and comes from smaller, uncontrolled studies, so the results deserve more skepticism.
A pilot study of men with what the researchers classified as “short penis” found that after six months of daily use, the mean gain was about 2.3 cm in flaccid length and 1.7 cm in stretched length.
7PubMed. A pilot phase-II prospective study to test the ‘efficacy’ and tolerability of a penile-extender device in the treatment of ‘short penis’Another study reported flaccid length going from about 8.8 cm to 10.5 cm over three months, and stretched length increasing from about 11.5 cm to 13.2 cm.
8PubMed. Effect of penile-extender device in increasing penile size in men with shortened penis: preliminary resultsA study in men with penile dysmorphophobia (dissatisfaction with penile size despite being within the normal range) found more modest gains: about 1.7 cm in flaccid length, 1.3 cm in stretched length, and 1.2 cm in erect length after six months. The researchers described no major complications and noted psychological benefits alongside the physical ones.
9The Journal of Sexual Medicine. Applying Extender Devices in Patients with Penile Dysmorphophobia: Assessment of Tolerability, Efficacy, and Impact on Erectile FunctionOne consistent limitation: erect length gains tend to be smaller than flaccid or stretched gains. Some studies do not even report erect measurements. The gains that sound most impressive (2+ cm) are usually flaccid measurements, which naturally have more variability. If your primary concern is erect length, the realistic expectation is probably closer to 1 cm over several months of dedicated use.
Recovery After Prostate Surgery
One of the more practical applications that has gained attention is using traction after radical prostatectomy. Prostate removal commonly leads to penile shortening, sometimes by a centimeter or more, because of changes in blood flow, nerve damage, and tissue contraction during healing. Traction therapy has been explored as a way to counteract this.
A randomized controlled trial found that men who began traction one month after surgery maintained significantly more length at six months compared to controls: the traction group gained about 1.6 cm on average while the control group gained only about 0.3 cm. The traction group also had better erectile function scores and higher satisfaction with sexual intercourse.
10PubMed. Efficacy of a Novel Penile Traction Device in Improving Penile Length and Erectile Function Post Prostatectomy: Results from a Single-Center Randomized, Controlled TrialA follow-up phase of the same research program found that benefits were maintained even after men stopped using the device, suggesting the tissue remodeling is durable rather than temporary.
11PubMed. Efficacy of RestoreX after prostatectomy: open-label phase of a randomized controlled trialStill, as a recent review noted, the long-term data remain limited, and more multi-center research is needed before traction can be considered a standard part of post-surgical rehabilitation.
12International Journal of Impotence Research. The role of vacuum erection device and penile traction therapy in the patients after radical prostatectomy: a narrative reviewBefore Penile Implant Surgery
Another surgical application involves using traction before penile prosthesis implantation. Men who have lost penile length due to Peyronie’s disease, prior surgery, or other causes sometimes worry that a prosthesis will not restore satisfactory length. A pilot study had men use traction for two to four hours daily for up to four months before implant surgery. Seventy percent gained measurable erect length (up to 1.5 cm), and none experienced length loss after the prosthesis was placed.
13PubMed. Traction therapy for men with shortened penis prior to penile prosthesis implantation: a pilot studyThe logic here is straightforward: stretching the tissue before surgery gives the surgeon more length to work with and reduces the chance the patient will be disappointed with the final result. It is a small study, but the concept is appealing enough that it has been incorporated into pre-surgical planning at some centers.
14PubMed Central. Strategies for maintaining penile size following penile implantSafety and Side Effects
The safety profile of traction devices is reassuring across the literature. No serious adverse events have been reported in clinical trials. Minor complaints include skin irritation at the contact points, temporary numbness or tingling (which resolves after removing the device), mild bruising, and occasional discomfort. None of the controlled trials have reported cases of tissue damage, loss of sensation, or worsened erectile function.
The study involving men with penile dysmorphophobia specifically assessed erectile function throughout the treatment period and found no negative effects.
9The Journal of Sexual Medicine. Applying Extender Devices in Patients with Penile Dysmorphophobia: Assessment of Tolerability, Efficacy, and Impact on Erectile FunctionThat said, nearly all the available safety data come from supervised clinical trials where participants received instruction on proper device use. Someone buying a device online without guidance and using it with excessive force or for excessive durations is operating outside what the evidence can speak to. Common sense applies: if you feel pain, numbness that does not resolve quickly, or skin breakdown, you should stop and reassess rather than push through.
The Compliance Problem
The biggest practical challenge with traction therapy is wearing the device long enough to see results. Studies showing the best outcomes require four to eight hours of daily use for three to six months. That is a considerable lifestyle ask. You have to find time in your day when you can wear a mechanical device on your penis, which limits what activities you can comfortably do. Some devices are discreet enough to wear under loose clothing while sitting at a desk, but others are less practical for everyday use.
Researchers have repeatedly flagged compliance as a major limitation. A review of the literature noted that current studies are constrained by small cohorts and poor patient adherence, and that improving compliance is one of the most important priorities for future research.
15PubMed Central. The use of penile traction therapy in the management of Peyronie’s disease: current evidence and future prospectsThe dose-response evidence from the Peyronie’s trials makes the compliance issue more concrete. In the multicentre Penimaster PRO study, men who managed more than six hours daily saw about twice the curvature reduction of those averaging fewer than four hours.
4PubMed. Penile traction therapy with the new device ‘Penimaster PRO’ is effective and safe in the stable phase of Peyronie’s disease: a controlled multicentre studyIf you can realistically commit to only an hour a day, you may still see some benefit, especially if you are combining traction with another treatment, but tempered expectations are in order.
What the Device Will Not Do
Traction devices are not a cure-all, and the marketing around some consumer products can create unrealistic expectations. A few things to keep in mind:
- Girth gains are minimal or absent. Nearly all the measured improvements are in length and curvature. Traction applies a longitudinal stretch, not a radial one, and the studies do not show meaningful increases in circumference.
- Results take months. This is not a quick fix. Measurable changes typically require at least three months of consistent use, and the best results in studies come at the six-month mark or beyond.
- Gains have limits. A narrative review summarizing modern device outcomes reported average length gains of about 1.5 to 2.3 cm and curvature reductions of 20 to 30 percent. 16PubMed Central. Penile Traction Therapy for Peyronie’s Disease: A Contemporary Narrative Review of Clinical Evidence and Evolving Trends
- Severe curvature may still need surgery. Men with curvature beyond 60 or 70 degrees, or those who cannot have intercourse due to the bend, are usually better served by surgical correction. Traction can be a useful adjunct before or after surgery, but expecting it to fully correct a severe deformity is not realistic.
Choosing and Using a Device
If you are considering traction therapy, there are a few practical considerations worth thinking through. Devices used in clinical research include the RestoreX (designed specifically for Peyronie’s disease with a directional fulcrum), the Penimaster PRO (which uses a vacuum attachment rather than a strap), and several rod-based extender devices. Not all products sold online have been tested in clinical trials, and some make claims that go well beyond any published evidence.
A urologist familiar with the literature can help you choose an appropriate device and set up a realistic protocol. Starting with lower tension and shorter sessions, then gradually increasing both, helps minimize discomfort and skin irritation. Most study protocols recommend breaks every one to two hours during daily wear. Keeping a log of hours worn can help you track whether you are hitting the threshold likely to produce results.
For men with Peyronie’s disease specifically, traction makes the most sense during the stable phase of the disease, after the initial inflammatory period (which can last 12 to 18 months) has resolved. Using traction during the acute phase, when the plaque is still forming and the penis may be painful, has not been well studied and could theoretically make inflammation worse. Your urologist can help determine which phase you are in based on your symptoms and history.